Drug Shortage Report for NOREPINEPHRINE BITARTRATE INJECTION USP

Last updated on 2022-09-14 History
Report ID 159863
Drug Identification Number 02485680
Brand name NOREPINEPHRINE BITARTRATE INJECTION USP
Common or Proper name Norepinephrine Bitartrate Injection
Company Name GENERIC MEDICAL PARTNERS INC
Market Status MARKETED
Active Ingredient(s) NOREPINEPHRINE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 1mg/ml 4 ml ampoule, pack of ten ampoules
ATC code C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-05-02
Actual start date 2022-05-02
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-09-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1500 DON MILLS ROAD, SUITE 711
TORONTO, ONTARIO
CANADA M3B 3K4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2022-09-14 French Compare
v8 2022-09-14 English Compare
v7 2022-05-03 English Compare
v6 2022-05-02 French Compare
v5 2022-05-02 English Compare
v4 2022-05-02 French Compare
v3 2022-05-02 French Compare
v2 2022-05-02 English Compare
v1 2022-05-02 English Compare

Showing 1 to 9 of 9